Juvenile idiopathic arthritis complicated by amyloidosis with secondary nephrotic syndrome - Effective treatment with tocilizumab

3Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

A case report of a boy with juvenile idiopathic arthritis since the age of 2 years, generalized onset, complicated by nephrotic syndrome due to secondary type A amyloidosis is presented. In the patient the disease had an especially severe course, complicated by frequent infections, making routine treatment dificult. Amyloidosis was diagnosed in the 5 th year of the disease based on a rectal biopsy. Since the disease onset the boy has been taking prednisolone and sequentially cyclosporine A, methotrexate, chlorambucil, etanercept, and cyclophosphamide. Clinical and laboratory remission was observed after treatment with tocilizumab. After 42 months of treatment with tocilizumab the boy's condition is good. There is no pain or joint edema, and no signs of nephrotic syndrome.

Cite

CITATION STYLE

APA

Kwiatkowska, M., Jednacz, E., & Rutkowska-Sak, L. (2015). Juvenile idiopathic arthritis complicated by amyloidosis with secondary nephrotic syndrome - Effective treatment with tocilizumab. Reumatologia, 53(3), 157–160. https://doi.org/10.5114/reum.2015.53138

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free